Incidence of Adverse and Safety Events in Individuals With Parkinson’s Disease Treated With Catechol-O-Methyltransferase Inhibitor Opicapone As an Add-on to Levodopa Treatment: A Systematic Review and Meta-Analysis. Prospect. Pharm. Sci. 2025, 23 (4), 175-185. https://doi.org/10.56782/pps.563.